Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9354823rdf:typepubmed:Citationlld:pubmed
pubmed-article:9354823lifeskim:mentionsumls-concept:C1527169lld:lifeskim
pubmed-article:9354823lifeskim:mentionsumls-concept:C0043157lld:lifeskim
pubmed-article:9354823lifeskim:mentionsumls-concept:C0013018lld:lifeskim
pubmed-article:9354823lifeskim:mentionsumls-concept:C0032202lld:lifeskim
pubmed-article:9354823lifeskim:mentionsumls-concept:C0220938lld:lifeskim
pubmed-article:9354823lifeskim:mentionsumls-concept:C1707455lld:lifeskim
pubmed-article:9354823lifeskim:mentionsumls-concept:C1442989lld:lifeskim
pubmed-article:9354823lifeskim:mentionsumls-concept:C0442711lld:lifeskim
pubmed-article:9354823pubmed:issue10lld:pubmed
pubmed-article:9354823pubmed:dateCreated1997-11-28lld:pubmed
pubmed-article:9354823pubmed:abstractTextIt is necessary to protect patients from white cell (WBC)-caused side effects of platelet transfusion by reducing the WBC contamination in single-donor platelets.lld:pubmed
pubmed-article:9354823pubmed:languageenglld:pubmed
pubmed-article:9354823pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9354823pubmed:citationSubsetIMlld:pubmed
pubmed-article:9354823pubmed:statusMEDLINElld:pubmed
pubmed-article:9354823pubmed:monthOctlld:pubmed
pubmed-article:9354823pubmed:issn0041-1132lld:pubmed
pubmed-article:9354823pubmed:authorpubmed-author:ZimmermannRRlld:pubmed
pubmed-article:9354823pubmed:authorpubmed-author:GlaserAAlld:pubmed
pubmed-article:9354823pubmed:authorpubmed-author:EcksteinRRlld:pubmed
pubmed-article:9354823pubmed:authorpubmed-author:ZingsemJJlld:pubmed
pubmed-article:9354823pubmed:authorpubmed-author:WeisbachVVlld:pubmed
pubmed-article:9354823pubmed:authorpubmed-author:van WaegGGlld:pubmed
pubmed-article:9354823pubmed:issnTypePrintlld:pubmed
pubmed-article:9354823pubmed:volume37lld:pubmed
pubmed-article:9354823pubmed:ownerNLMlld:pubmed
pubmed-article:9354823pubmed:authorsCompleteYlld:pubmed
pubmed-article:9354823pubmed:pagination1045-9lld:pubmed
pubmed-article:9354823pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:9354823pubmed:meshHeadingpubmed-meshheading:9354823-...lld:pubmed
pubmed-article:9354823pubmed:meshHeadingpubmed-meshheading:9354823-...lld:pubmed
pubmed-article:9354823pubmed:meshHeadingpubmed-meshheading:9354823-...lld:pubmed
pubmed-article:9354823pubmed:meshHeadingpubmed-meshheading:9354823-...lld:pubmed
pubmed-article:9354823pubmed:meshHeadingpubmed-meshheading:9354823-...lld:pubmed
pubmed-article:9354823pubmed:meshHeadingpubmed-meshheading:9354823-...lld:pubmed
pubmed-article:9354823pubmed:meshHeadingpubmed-meshheading:9354823-...lld:pubmed
pubmed-article:9354823pubmed:year1997lld:pubmed
pubmed-article:9354823pubmed:articleTitleComparison of COBE white cell-reduction and standard plateletpheresis protocols in the same donors.lld:pubmed
pubmed-article:9354823pubmed:affiliationDepartment of Transfusion Medicine and Haemostaseology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany.lld:pubmed
pubmed-article:9354823pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9354823pubmed:publicationTypeComparative Studylld:pubmed